CHM chimeric therapeutics limited

Bell Potter Securities Limited will act as Lead Manager to the...

  1. 14,266 Posts.
    lightbulb Created with Sketch. 4257
    Bell Potter Securities Limited will act as Lead Manager to the Entitlement Offer (including any
    shortfall
    to the Entitlement Offer).

    The Entitlement Offer will include a top up facility under which eligible shareholders who take
    up their full Entitlement will be invited to apply for additional shares in the Entitlement Offer
    from a pool of those not taken up by other eligible shareholders. There is no guarantee that
    applicants under this top up facility will receive all or any of the shares they apply for under the
    facility.

    That's the guys lining up at 3c and 2.9c, most likely organised by Bell Potter. Buy at 3c or less plus 2.8c entitlement. Even blind Freddy can see what's going on.

    This is CODE for UNDERWRITTEN

    Anyway, not relevant anymore for me. Just salvaging what's possible and moving on.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.001(16.7%)
Mkt cap ! $11.37M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $2.689K 768.2K

Buyers (Bids)

No. Vol. Price($)
77 71159139 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 83645026 25
View Market Depth
Last trade - 10.53am 01/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.